https://pubmed.ncbi.nlm.nih.gov/41997505/ Ketamine for Depression in Serious Illness: Evidence, Safety, and Practical Approaches (2026) “Safety across serious illness studies is generally favorable, with transient dissociation, hypertension, and somnolence the most common adverse effects; serious adverse events remain rare. #Ketamine and #esketamine offer the strongest evidence among rapid-acting antidepressants and may be preferred when urgent symptom relief is needed.” #mentalhealth #psychedelics
Ketamine for Depression in Serious Illness: Evidence, Safety, and Practical Approaches - PubMed

Patients with serious illness and short prognoses often experience depression and suicidal ideation. Traditional antidepressants are limited by delayed onset, creating a need for rapidly acting therapies. In this Palliative Care Rounds, we examine the evidence for ketamine/esketamine's efficacy as a …

PubMed
Spotlight: Psychedelics in Palliative Care, Ready for Primetime! Making the Case for Ketamine-Assisted Psychotherapy (Horowitz, et al, 2024)

"Preliminary evidence demonstrates that Ketamine-Assisted Psychotherapy (KAP) can significantly improve depression, demoralization and existential distress in seriously ill people"

Psychedelic Mental Health Institute
https://pubmed.ncbi.nlm.nih.gov/41987516/ #ketamine for acute pain in older adults in the er (2026) #esketamine
Acute pain management in older adults presenting to the emergency department: a clinical review - PubMed

Managing acute pain in older adults is a complex challenge in emergency care, influenced by age-related physiological changes, multimorbidity and altered pharmacokinetics. Inadequate treatment contributes to frailty, delirium, functional decline and reduced quality of life, yet oligoanalgesia remain …

PubMed
https://jamanetwork.com/journals/jamapsychiatry/article-abstract/2847667 #Ketamine and #esketamine can be tested as active placebos and administered in all the ways other psychedelic medicines are. These medicines are FDA approved and have been studied for 60+ years. Compare #psychedelics in a double blind study with ketamine. Wild that this isn’t the common approach in #psychedelicresearch
A Systematic Review and Meta-Analysis of the Efficacy and Safety of Intranasal Esketamine for Rapid Symptom Relief in Treatment-resistant Depression (Saun, et al, 2026) https://pubmed.ncbi.nlm.nih.gov/41968732/ These findings support intranasal esketamine as a rapidly acting intervention for TRD, consistent with emerging evidence on glutamatergic modulation. #ketamine #esketamine #psychedelics #depression #spravato
A Systematic Review and Meta-Analysis of the Efficacy and Safety of Intranasal Esketamine for Rapid Symptom Relief in Treatment-resistant Depression - PubMed

Esketamine demonstrates efficacy in achieving rapid relief of depressive symptoms in TRD, but findings must be interpreted with caution, given the heterogeneity and adverse event profile. Further high-quality, long-term studies are warranted to establish sustained efficacy and safety.

PubMed
Psychedelics as a potential treatment for borderline personality disorder: A narrative review - PubMed

Borderline personality disorder (BPD) is a serious mental illness with high rates of morbidity and stigma; however, successful remission is frequently limited by a paucity of accessible treatment options. In an era of growing interest in psychedelics as novel psychiatric treatment modalities, patien …

PubMed
New Preprint paper suggests #esketamine (#spravato) a variant of #ketamine is a #psychedelic that causes mystical experiences which are related to therapeutic outcome in a real world, observational long term study https://pubmed.ncbi.nlm.nih.gov/41959772/
Mystical Experience Induced by Esketamine Treatment: A Real-World Observational Study - PubMed

Esketamine is a fast-acting antidepressant drug which induces acute psychoactive effects. The most frequent is a dissociative state which seems unrelated to therapeutic efficacy. Other esketamine-induced effects, including psychedelic-like mystical experiences, have been poorly studied in terms of p …

PubMed
Mystical Experience Induced by Esketamine Treatment: A Real-World Observational Study
(Mallevays, et al., 2026) https://pubmed.ncbi.nlm.nih.gov/41959772/ “These findings add to the growing body of evidence suggesting that psychedelic-like mystical experiences may be associated to therapeutic efficacy, not only in classic psychedelic-assisted therapy, but also in esketamine treatment.” Another study suggesting #esketamine #ketamine is #psychedelic And that the #mysticalexperience affects therapeutic outcomes.
Mystical Experience Induced by Esketamine Treatment: A Real-World Observational Study - PubMed

Esketamine is a fast-acting antidepressant drug which induces acute psychoactive effects. The most frequent is a dissociative state which seems unrelated to therapeutic efficacy. Other esketamine-induced effects, including psychedelic-like mystical experiences, have been poorly studied in terms of p …

PubMed
An international mega-analysis of psychedelic drug effects on brain circuit function https://www.nature.com/articles/s41591-026-04287-9 research opportunity- now compare outcomes to #ketamine and #esketamine which are currently used medicines.
An international mega-analysis of psychedelic drug effects on brain circuit function - Nature Medicine

Analysis of neuroimaging datasets across five major psychedelics revealed a shared brain signature and provides a comprehensive insight into how these drugs reorganize brain architecture.

Nature

I've tried almost a dozen different medications once I finally sought treatment for my lifelong depression in my early twenties. Some would work for a while and then stop. Others worked but had side effects such as when people referred to me as a "zombie", increasing my suicidal ideation, causing panic attacks, severe nausea and vomiting, screwing up my metabolism, tanking my libido, or making me prone to fits of rage.

It's been like that for 25 years. The reelection of 45 to 47 put me in a slump that I could not get out of. I took care of my disabled wife. I did not cook. I did not clean. I did not take care of myself. My personal hygiene practically stopped, other than brushing and flossing which I've turned into a ritual. I honestly didn't know how much longer I could stay here, in this world, in this plane of existence. I was more than ready.

I had been looking at alternative treatments including ECT, TMS, and psychedelics. But I didn't really think any of them would help either.

I have a cousin who also had treatment resistant depression her whole life who tried esketamine. She told me that you would have to go in multiple times a week and be there for 2 hours at a time. She told me it takes a long time for it to start working. But she also told me it "removed the blanket". She described her depression as a blanket covering her. I described mine as being in a bubble or carrying a heavy weight. I understood what she meant.

I found out my insurance would cover it and that there was a facility to administer it in my suburb.

I started at the end of January. I hated missing work. It increased my anxiety and depression. I didn't like the way Spravato (the brand name) made me feel. I took too long to recover. The facility, while staffed by a psychiatrist a PA and multiple technicians, felt sketchy. I felt like I was in an opium den.

You only go twice a week for one month. Then you drop to once a week. Eventually you can get down to twice a month or once a month depending on the person.

I was told up front that some people do not see results until week 12. They call the run up to that the "induction phase".

Toward the second half of March, something flipped in my brain. I felt " better". I feel like I haven't felt since elementary school. I feel like the best version of myself. This isn't mania; I felt that before. This is distance and objectivity. I am able to see myself almost like others see me. I am able to watch depression triggers and sometimes intervene.

I honestly didn't think I deserved to feel this way. I lived so many years believing my depression was something I earned. I also thought that if I wasn't depressed I would no longer be myself. All of that was just part of the depression.

I still have my other problems. I still have anxiety. I still have ADHD. I'm still autistic. I still have cPTSD from a decade of abuse. I still have meltdowns. But that haze, that fog that used to cover everything has lifted.

I'm cooking again. I'm keeping the kitchen clean. I'm tearing down cardboard boxes, cleaning the garage a little. I'm becoming human again.

Every time I think about it I start tearing up. I didn't think this would ever happen. I didn't think I would ever not be depressed.

I could have given up many times. But my wife needs me, our cats need me, my mom and dad still love me. I stayed because of them, not me.

I think... I think I might be able to stay for myself now.

If you are suffering from clinical, lifelong, treatment resistant depression. Please do not give up. Please seek out treatments. If the treatments don't work, find another one.

This is not a kind world. The people in charge are the worst of us. But they are not all of us. We need people with empathy, people who can feel. Please stay. Please keep looking. Please don't give up.

#Depression #ClinicalDepression #TreatmentResistentDepression #Spravato #Esketamine #EsketamineForDepression